跳至主要内容
临床试验/NL-OMON53114
NL-OMON53114招募中不适用

etherlands Cohort Study on Acute HIV Infection - NOVA study

Academisch Medisch Centrum0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet the
  • following criteria:
  • -Written informed consent to store samples and perform genetic testing.
  • -Separate written informed consent for invasive sampling procedures:
  • leukapheresis, sigmoidoscopy with biopsies, lymph node biopsy or excision
  • biopsy and lumbar puncture, to store samples and perform genetic testing. - Age
  • >= 18 years
  • - An acute HIV-1 infection, defined according to the modified Fiebig stages
  • I-IV, as described in the previous paragraph (HIV-1 RNA positive and 4th
  • generation ELISA negative or HIV-1 RNA positive and 4th generation HIV ELISA
  • positive with indeterminate Western Blot). Patients in Fiebig stage V and VI
  • will only be included if they have a documented negative HIV test 6 months
  • prior to the (first) positive test.
  • -Female subjects should be willing to use adequate contraception.
  • Chronic control group:
  • -Written informed consent to store samples and perform genetic testing
  • -Separate written informed consent for sampling procedure: leukapheresis (or
  • large blood draw), and/or lymph node excision biopsy, with storage of samples
  • -Age >= 18 years
  • -ART initiated in the chronic infection phase and chronic HIV-infection as
  • confirmed by Western Blot (p31 positive)
  • -Three to 5 years on ART with undetectable viral load and no more than two
  • consecutive blips of >100 HIV RNA copies per mL of plasma in the year before
  • Elite control group:
  • -Written informed consent to store samples and perform genetic testing
  • -Separate written informed consent for sampling procedure: leukapheresis (or
  • large blood draw), and/or lymph node excision biopsy, with storage of samples
  • -Age >= 18 years
  • -Natural control of HIV infection, defined as having 3 undetectable HIV-1 RNA
  • measurements >12 months upon diagnosis or 90% of HIV-1 RNA measurements
  • undetectable >10 years.

排除标准

  • -Contraindication for proposed cART regimen (e.g. impaired renal function) for
  • participants enrolled with an acute HIV infection
  • -Mental disorder that in the view of the investigator would interfere with
  • adherence to the treatment or the study procedures, or the decision to
  • participate in the study.
  • -Immunosuppressive medication or other diseases associated with
  • immunodeficiency.

研究者

相似试验